25 XP   0   0   10

Dr. Lal Path Labs Ltd.
Buy, Hold or Sell?

Let's analyse Dr. Lal Path Labs Ltd. together

PenkeI guess you are interested in Dr. Lal Path Labs Ltd.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Dr. Lal Path Labs Ltd.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Dr. Lal Path Labs Ltd.

I send you an email if I find something interesting about Dr. Lal Path Labs Ltd..

Quick analysis of Dr. Lal Path Labs Ltd. (30 sec.)










What can you expect buying and holding a share of Dr. Lal Path Labs Ltd.? (30 sec.)

How much money do you get?

How much money do you get?
INR0.59
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR204.34
Expected worth in 1 year
INR279.35
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR124.55
Return On Investment
5.2%

For what price can you sell your share?

Current Price per Share
INR2,388.35
Expected price per share
INR1,944 - INR2,487
How sure are you?
50%

1. Valuation of Dr. Lal Path Labs Ltd. (5 min.)




Live pricePrice per Share (EOD)

INR2,388.35

Intrinsic Value Per Share

INR291.89 - INR618.55

Total Value Per Share

INR496.23 - INR822.90

2. Growth of Dr. Lal Path Labs Ltd. (5 min.)




Is Dr. Lal Path Labs Ltd. growing?

Current yearPrevious yearGrowGrow %
How rich?$203.9m$185.2m$18.7m9.2%

How much money is Dr. Lal Path Labs Ltd. making?

Current yearPrevious yearGrowGrow %
Making money$28.6m$41.3m-$12.7m-44.3%
Net Profit Margin11.8%16.5%--

How much money comes from the company's main activities?

3. Financial Health of Dr. Lal Path Labs Ltd. (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#59 / 145

Most Revenue
#43 / 145

Most Profit
#32 / 145

What can you expect buying and holding a share of Dr. Lal Path Labs Ltd.? (5 min.)

Welcome investor! Dr. Lal Path Labs Ltd.'s management wants to use your money to grow the business. In return you get a share of Dr. Lal Path Labs Ltd..

What can you expect buying and holding a share of Dr. Lal Path Labs Ltd.?

First you should know what it really means to hold a share of Dr. Lal Path Labs Ltd.. And how you can make/lose money.

Speculation

The Price per Share of Dr. Lal Path Labs Ltd. is INR2,388. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Dr. Lal Path Labs Ltd..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Dr. Lal Path Labs Ltd., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR204.34. Based on the TTM, the Book Value Change Per Share is INR18.75 per quarter. Based on the YOY, the Book Value Change Per Share is INR32.17 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR12.38 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Dr. Lal Path Labs Ltd..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.340.0%0.340.0%0.500.0%0.380.0%0.280.0%
Usd Book Value Change Per Share0.230.0%0.230.0%0.390.0%0.260.0%0.220.0%
Usd Dividend Per Share0.150.0%0.150.0%0.170.0%0.150.0%0.090.0%
Usd Total Gains Per Share0.370.0%0.370.0%0.550.0%0.410.0%0.310.0%
Usd Price Per Share21.94-21.94-31.33-23.02-14.83-
Price to Earnings Ratio63.64-63.64-62.97-59.80-45.19-
Price-to-Total Gains Ratio58.71-58.71-56.52-54.30-50.03-
Price to Book Ratio8.95-8.95-14.07-12.17-9.72-
Price-to-Total Gains Ratio58.71-58.71-56.52-54.30-50.03-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share28.6602
Number of shares34
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.150.15
Usd Book Value Change Per Share0.230.26
Usd Total Gains Per Share0.370.41
Gains per Quarter (34 shares)12.7014.07
Gains per Year (34 shares)50.8256.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1203141213546
24061924271102
3619214362106158
48112219483142214
5101153245104177270
6121184296125213326
7141214347146248382
8162245398166284438
9182275449187319494
10202306500208355550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%13.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%13.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%13.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%13.00.00.0100.0%

Fundamentals of Dr. Lal Path Labs Ltd.

About Dr. Lal Path Labs Ltd.

Dr. Lal PathLabs Limited engages in the operation of laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

Fundamental data was last updated by Penke on 2024-04-14 03:32:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Dr. Lal Path Labs Ltd..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Dr. Lal Path Labs Ltd. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Dr. Lal Path Labs Ltd. to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 11.8% means that ₹0.12 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Dr. Lal Path Labs Ltd.:

  • The MRQ is 11.8%. The company is making a huge profit. +2
  • The TTM is 11.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ11.8%TTM11.8%0.0%
TTM11.8%YOY16.5%-4.7%
TTM11.8%5Y16.5%-4.7%
5Y16.5%10Y16.1%+0.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ11.8%-6.7%+18.5%
TTM11.8%-6.7%+18.5%
YOY16.5%0.3%+16.2%
5Y16.5%-1.5%+18.0%
10Y16.1%-3.4%+19.5%
1.1.2. Return on Assets

Shows how efficient Dr. Lal Path Labs Ltd. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dr. Lal Path Labs Ltd. to the Diagnostics & Research industry mean.
  • 10.0% Return on Assets means that Dr. Lal Path Labs Ltd. generated ₹0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Dr. Lal Path Labs Ltd.:

  • The MRQ is 10.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 10.0%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ10.0%TTM10.0%0.0%
TTM10.0%YOY14.7%-4.6%
TTM10.0%5Y15.9%-5.9%
5Y15.9%10Y18.2%-2.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ10.0%-1.3%+11.3%
TTM10.0%-1.3%+11.3%
YOY14.7%-0.9%+15.6%
5Y15.9%-0.5%+16.4%
10Y18.2%-0.9%+19.1%
1.1.3. Return on Equity

Shows how efficient Dr. Lal Path Labs Ltd. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dr. Lal Path Labs Ltd. to the Diagnostics & Research industry mean.
  • 14.3% Return on Equity means Dr. Lal Path Labs Ltd. generated ₹0.14 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Dr. Lal Path Labs Ltd.:

  • The MRQ is 14.3%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 14.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.3%TTM14.3%0.0%
TTM14.3%YOY22.9%-8.5%
TTM14.3%5Y21.3%-6.9%
5Y21.3%10Y23.9%-2.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ14.3%-0.5%+14.8%
TTM14.3%-+14.3%
YOY22.9%0.3%+22.6%
5Y21.3%-1.4%+22.7%
10Y23.9%-2.3%+26.2%

1.2. Operating Efficiency of Dr. Lal Path Labs Ltd..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dr. Lal Path Labs Ltd. is operating .

  • Measures how much profit Dr. Lal Path Labs Ltd. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dr. Lal Path Labs Ltd. to the Diagnostics & Research industry mean.
  • An Operating Margin of 18.9% means the company generated ₹0.19  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Dr. Lal Path Labs Ltd.:

  • The MRQ is 18.9%. The company is operating efficient. +1
  • The TTM is 18.9%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ18.9%TTM18.9%0.0%
TTM18.9%YOY24.0%-5.1%
TTM18.9%5Y23.6%-4.7%
5Y23.6%10Y23.6%+0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ18.9%-6.2%+25.1%
TTM18.9%0.5%+18.4%
YOY24.0%4.0%+20.0%
5Y23.6%3.7%+19.9%
10Y23.6%-1.3%+24.9%
1.2.2. Operating Ratio

Measures how efficient Dr. Lal Path Labs Ltd. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.69 means that the operating costs are ₹0.69 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Dr. Lal Path Labs Ltd.:

  • The MRQ is 0.692. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.692. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.692TTM0.6920.000
TTM0.692YOY0.783-0.091
TTM0.6925Y0.687+0.004
5Y0.68710Y0.723-0.036
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6921.280-0.588
TTM0.6921.304-0.612
YOY0.7831.236-0.453
5Y0.6871.242-0.555
10Y0.7231.205-0.482

1.3. Liquidity of Dr. Lal Path Labs Ltd..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dr. Lal Path Labs Ltd. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 2.07 means the company has ₹2.07 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Dr. Lal Path Labs Ltd.:

  • The MRQ is 2.071. The company is able to pay all its short-term debts. +1
  • The TTM is 2.071. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.071TTM2.0710.000
TTM2.071YOY1.750+0.321
TTM2.0715Y3.561-1.490
5Y3.56110Y3.905-0.344
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0712.111-0.040
TTM2.0712.298-0.227
YOY1.7502.599-0.849
5Y3.5613.012+0.549
10Y3.9053.081+0.824
1.3.2. Quick Ratio

Measures if Dr. Lal Path Labs Ltd. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Dr. Lal Path Labs Ltd. to the Diagnostics & Research industry mean.
  • A Quick Ratio of 3.22 means the company can pay off ₹3.22 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Dr. Lal Path Labs Ltd.:

  • The MRQ is 3.215. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.215. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.215TTM3.2150.000
TTM3.215YOY2.215+1.000
TTM3.2155Y5.549-2.333
5Y5.54910Y5.858-0.309
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2151.204+2.011
TTM3.2151.319+1.896
YOY2.2151.602+0.613
5Y5.5491.943+3.606
10Y5.8582.203+3.655

1.4. Solvency of Dr. Lal Path Labs Ltd..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dr. Lal Path Labs Ltd. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Dr. Lal Path Labs Ltd. to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.29 means that Dr. Lal Path Labs Ltd. assets are financed with 28.8% credit (debt) and the remaining percentage (100% - 28.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Dr. Lal Path Labs Ltd.:

  • The MRQ is 0.288. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.288. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.288TTM0.2880.000
TTM0.288YOY0.344-0.057
TTM0.2885Y0.245+0.043
5Y0.24510Y0.229+0.016
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2880.429-0.141
TTM0.2880.407-0.119
YOY0.3440.394-0.050
5Y0.2450.450-0.205
10Y0.2290.450-0.221
1.4.2. Debt to Equity Ratio

Measures if Dr. Lal Path Labs Ltd. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Dr. Lal Path Labs Ltd. to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 41.2% means that company has ₹0.41 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Dr. Lal Path Labs Ltd.:

  • The MRQ is 0.412. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.412. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.412TTM0.4120.000
TTM0.412YOY0.537-0.125
TTM0.4125Y0.343+0.069
5Y0.34310Y0.315+0.028
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4120.606-0.194
TTM0.4120.571-0.159
YOY0.5370.631-0.094
5Y0.3430.658-0.315
10Y0.3150.735-0.420

2. Market Valuation of Dr. Lal Path Labs Ltd.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Dr. Lal Path Labs Ltd. generates.

  • Above 15 is considered overpriced but always compare Dr. Lal Path Labs Ltd. to the Diagnostics & Research industry mean.
  • A PE ratio of 63.64 means the investor is paying ₹63.64 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Dr. Lal Path Labs Ltd.:

  • The EOD is 83.147. Based on the earnings, the company is expensive. -2
  • The MRQ is 63.643. Based on the earnings, the company is expensive. -2
  • The TTM is 63.643. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD83.147MRQ63.643+19.504
MRQ63.643TTM63.6430.000
TTM63.643YOY62.967+0.676
TTM63.6435Y59.803+3.839
5Y59.80310Y45.185+14.618
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD83.147-0.235+83.382
MRQ63.643-0.395+64.038
TTM63.643-0.284+63.927
YOY62.9670.002+62.965
5Y59.8034.834+54.969
10Y45.1855.200+39.985
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Dr. Lal Path Labs Ltd.:

  • The EOD is 48.283. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 36.957. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 36.957. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD48.283MRQ36.957+11.326
MRQ36.957TTM36.9570.000
TTM36.957YOY-737.312+774.269
TTM36.9575Y-105.515+142.472
5Y-105.51510Y-32.729-72.786
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD48.283-0.277+48.560
MRQ36.957-0.441+37.398
TTM36.957-1.389+38.346
YOY-737.312-2.030-735.282
5Y-105.515-1.446-104.069
10Y-32.729-1.971-30.758
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Dr. Lal Path Labs Ltd. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 8.95 means the investor is paying ₹8.95 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Dr. Lal Path Labs Ltd.:

  • The EOD is 11.688. Based on the equity, the company is expensive. -2
  • The MRQ is 8.946. Based on the equity, the company is overpriced. -1
  • The TTM is 8.946. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD11.688MRQ8.946+2.742
MRQ8.946TTM8.9460.000
TTM8.946YOY14.067-5.121
TTM8.9465Y12.170-3.224
5Y12.17010Y9.724+2.446
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD11.6881.897+9.791
MRQ8.9462.222+6.724
TTM8.9462.168+6.778
YOY14.0673.041+11.026
5Y12.1703.477+8.693
10Y9.7244.125+5.599
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Dr. Lal Path Labs Ltd. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--18.75218.7520%32.166-42%21.751-14%18.466+2%
Book Value Per Share--204.341204.3410%185.589+10%156.886+30%109.023+87%
Current Ratio--2.0712.0710%1.750+18%3.561-42%3.905-47%
Debt To Asset Ratio--0.2880.2880%0.344-16%0.245+17%0.229+25%
Debt To Equity Ratio--0.4120.4120%0.537-23%0.343+20%0.315+31%
Dividend Per Share--12.38412.3840%14.027-12%12.741-3%7.637+62%
Eps--28.72428.7240%41.461-31%31.273-8%23.146+24%
Free Cash Flow Per Share--49.46549.4650%-3.541+107%26.483+87%18.954+161%
Free Cash Flow To Equity Per Share--15.41415.4140%12.866+20%13.713+12%12.178+27%
Gross Profit Margin--0.7870.7870%0.893-12%0.854-8%0.835-6%
Intrinsic Value_10Y_max--618.554--------
Intrinsic Value_10Y_min--291.891--------
Intrinsic Value_1Y_max--36.096--------
Intrinsic Value_1Y_min--21.771--------
Intrinsic Value_3Y_max--128.182--------
Intrinsic Value_3Y_min--72.277--------
Intrinsic Value_5Y_max--244.056--------
Intrinsic Value_5Y_min--129.920--------
Market Cap198638114160.000+23%152042345760.000152042345760.0000%217130874720.000-30%159550065552.000-5%102789308640.000+48%
Net Profit Margin--0.1180.1180%0.165-28%0.165-28%0.161-26%
Operating Margin--0.1890.1890%0.240-21%0.236-20%0.236-20%
Operating Ratio--0.6920.6920%0.783-12%0.687+1%0.723-4%
Pb Ratio11.688+23%8.9468.9460%14.067-36%12.170-26%9.724-8%
Pe Ratio83.147+23%63.64363.6430%62.967+1%59.803+6%45.185+41%
Price Per Share2388.350+23%1828.1001828.1000%2610.700-30%1918.370-5%1235.900+48%
Price To Free Cash Flow Ratio48.283+23%36.95736.9570%-737.312+2095%-105.515+386%-32.729+189%
Price To Total Gains Ratio76.705+23%58.71258.7120%56.518+4%54.296+8%50.031+17%
Quick Ratio--3.2153.2150%2.215+45%5.549-42%5.858-45%
Return On Assets--0.1000.1000%0.147-32%0.159-37%0.182-45%
Return On Equity--0.1430.1430%0.229-37%0.213-33%0.239-40%
Total Gains Per Share--31.13731.1370%46.193-33%34.493-10%26.103+19%
Usd Book Value--203940000.000203940000.0000%185224440.000+10%156577392.000+30%108809222.893+87%
Usd Book Value Change Per Share--0.2250.2250%0.386-42%0.261-14%0.222+2%
Usd Book Value Per Share--2.4522.4520%2.227+10%1.883+30%1.308+87%
Usd Dividend Per Share--0.1490.1490%0.168-12%0.153-3%0.092+62%
Usd Eps--0.3450.3450%0.498-31%0.375-8%0.278+24%
Usd Free Cash Flow--49368000.00049368000.0000%-3533880.000+107%26430792.000+87%18916791.252+161%
Usd Free Cash Flow Per Share--0.5940.5940%-0.042+107%0.318+87%0.227+161%
Usd Free Cash Flow To Equity Per Share--0.1850.1850%0.154+20%0.165+12%0.146+27%
Usd Market Cap2383657369.920+23%1824508149.1201824508149.1200%2605570496.640-30%1914600786.624-5%1233471703.680+48%
Usd Price Per Share28.660+23%21.93721.9370%31.328-30%23.020-5%14.831+48%
Usd Profit--28668000.00028668000.0000%41376000.000-31%31852872.000-10%23498330.852+22%
Usd Revenue--242028000.000242028000.0000%250473480.000-3%197261280.000+23%146368509.702+65%
Usd Total Gains Per Share--0.3740.3740%0.554-33%0.414-10%0.313+19%
 EOD+4 -4MRQTTM+0 -0YOY+16 -205Y+12 -2410Y+24 -12

3.2. Fundamental Score

Let's check the fundamental score of Dr. Lal Path Labs Ltd. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1583.147
Price to Book Ratio (EOD)Between0-111.688
Net Profit Margin (MRQ)Greater than00.118
Operating Margin (MRQ)Greater than00.189
Quick Ratio (MRQ)Greater than13.215
Current Ratio (MRQ)Greater than12.071
Debt to Asset Ratio (MRQ)Less than10.288
Debt to Equity Ratio (MRQ)Less than10.412
Return on Equity (MRQ)Greater than0.150.143
Return on Assets (MRQ)Greater than0.050.100
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Dr. Lal Path Labs Ltd. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.160
Ma 20Greater thanMa 502,292.988
Ma 50Greater thanMa 1002,279.638
Ma 100Greater thanMa 2002,403.784
OpenGreater thanClose2,330.650
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets23,855,000
Total Liabilities6,860,000
Total Stockholder Equity16,663,000
 As reported
Total Liabilities 6,860,000
Total Stockholder Equity+ 16,663,000
Total Assets = 23,855,000

Assets

Total Assets23,855,000
Total Current Assets9,730,000
Long-term Assets14,125,000
Total Current Assets
Cash And Cash Equivalents 2,637,000
Short-term Investments 5,873,000
Net Receivables 722,000
Inventory 338,000
Other Current Assets 160,000
Total Current Assets  (as reported)9,730,000
Total Current Assets  (calculated)9,730,000
+/-0
Long-term Assets
Property Plant Equipment 4,040,000
Goodwill 5,478,000
Intangible Assets 3,582,000
Other Assets 672,560
Long-term Assets  (as reported)14,125,000
Long-term Assets  (calculated)13,772,560
+/- 352,440

Liabilities & Shareholders' Equity

Total Current Liabilities4,698,000
Long-term Liabilities2,162,000
Total Stockholder Equity16,663,000
Total Current Liabilities
Short-term Debt 2,062,000
Short Long Term Debt 1,533,000
Accounts payable 1,561,000
Other Current Liabilities 316,000
Total Current Liabilities  (as reported)4,698,000
Total Current Liabilities  (calculated)5,472,000
+/- 774,000
Long-term Liabilities
Long term Debt Total 2,133,230
Long-term Liabilities  (as reported)2,162,000
Long-term Liabilities  (calculated)2,133,230
+/- 28,770
Total Stockholder Equity
Retained Earnings 14,530,710
Accumulated Other Comprehensive Income 1,507,180
Capital Surplus 934,880
Total Stockholder Equity (as reported)16,663,000
Total Stockholder Equity (calculated)16,972,770
+/- 309,770
Other
Capital Stock834,000
Cash And Equivalents2,502,080
Cash and Short Term Investments 8,510,000
Common Stock Shares Outstanding 83,125
Current Deferred Revenue759,000
Liabilities and Stockholders Equity 23,855,000
Net Debt 1,558,000
Net Invested Capital 19,029,000
Net Working Capital 5,032,000
Property Plant and Equipment Gross 4,040,000
Short Long Term Debt Total 4,195,000



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-31
> Total Assets 
1,696,530
1,770,470
2,690,200
3,515,220
4,753,080
6,252,306
7,641,735
9,188,810
10,905,000
13,743,060
16,613,300
23,532,200
23,855,000
23,855,00023,532,20016,613,30013,743,06010,905,0009,188,8107,641,7356,252,3064,753,0803,515,2202,690,2001,770,4701,696,530
   > Total Current Assets 
439,390
419,580
1,167,450
1,703,260
2,816,750
4,237,356
5,106,248
6,230,160
8,136,310
8,926,460
11,451,700
8,751,510
9,730,000
9,730,0008,751,51011,451,7008,926,4608,136,3106,230,1605,106,2484,237,3562,816,7501,703,2601,167,450419,580439,390
       Cash And Cash Equivalents 
44,470
79,760
172,950
157,640
232,840
172,478
150,515
200,480
1,293,870
1,967,200
2,442,980
3,781,950
2,637,000
2,637,0003,781,9502,442,9801,967,2001,293,870200,480150,515172,478232,840157,640172,95079,76044,470
       Short-term Investments 
190,200
102,370
589,390
984,880
1,628,180
2,752,691
3,276,708
4,351,510
5,442,360
5,350,240
7,397,270
3,034,600
5,873,000
5,873,0003,034,6007,397,2705,350,2405,442,3604,351,5103,276,7082,752,6911,628,180984,880589,390102,370190,200
       Net Receivables 
0
0
0
286,840
701,388
429,550
486,980
508,440
1,111,240
1,036,260
1,068,870
1,225,550
722,000
722,0001,225,5501,068,8701,036,2601,111,240508,440486,980429,550701,388286,840000
       Inventory 
77,540
62,280
86,260
116,590
142,780
145,150
179,072
273,350
285,350
569,600
425,580
525,410
338,000
338,000525,410425,580569,600285,350273,350179,072145,150142,780116,59086,26062,28077,540
       Other Current Assets 
127,180
175,170
318,850
444,150
812,950
1,167,037
1,499,953
1,404,820
3,490
3,160
117,000
184,000
160,000
160,000184,000117,0003,1603,4901,404,8201,499,9531,167,037812,950444,150318,850175,170127,180
   > Long-term Assets 
1,257,140
1,350,890
1,522,750
1,811,960
1,936,330
2,014,951
2,535,487
2,958,650
2,768,690
4,816,600
5,161,600
14,780,690
14,125,000
14,125,00014,780,6905,161,6004,816,6002,768,6902,958,6502,535,4872,014,9511,936,3301,811,9601,522,7501,350,8901,257,140
       Property Plant Equipment 
707,630
710,980
758,390
772,500
915,040
1,123,562
1,300,907
1,693,520
1,635,550
3,021,020
3,176,220
4,448,510
4,040,000
4,040,0004,448,5103,176,2203,021,0201,635,5501,693,5201,300,9071,123,562915,040772,500758,390710,980707,630
       Goodwill 
205,780
208,240
297,920
427,640
433,950
436,410
592,935
312,170
279,740
772,260
853,600
5,499,040
5,478,000
5,478,0005,499,040853,600772,260279,740312,170592,935436,410433,950427,640297,920208,240205,780
       Long Term Investments 
0
0
0
4,130
2,437
2,192
68,820
265,370
203,000
0
0
0
0
0000203,000265,37068,8202,1922,4374,130000
       Intangible Assets 
210,160
225,850
214,450
199,840
161,270
137,369
185,080
198,180
205,740
450,700
595,080
4,105,570
3,582,000
3,582,0004,105,570595,080450,700205,740198,180185,080137,369161,270199,840214,450225,850210,160
       Long-term Assets Other 
110,400
177,110
123,150
215,720
172,070
197,134
296,679
4,632,290
5,709,060
5,555,230
7,614,010
3,510,190
6,093,000
6,093,0003,510,1907,614,0105,555,2305,709,0604,632,290296,679197,134172,070215,720123,150177,110110,400
> Total Liabilities 
761,590
599,730
1,053,470
1,181,900
1,319,320
1,157,237
1,019,812
1,239,110
1,395,210
3,202,790
3,853,150
8,096,830
6,860,000
6,860,0008,096,8303,853,1503,202,7901,395,2101,239,1101,019,8121,157,2371,319,3201,181,9001,053,470599,730761,590
   > Total Current Liabilities 
638,820
486,630
890,920
973,570
1,117,560
907,817
736,566
1,159,580
1,383,040
2,273,070
2,742,850
4,999,880
4,698,000
4,698,0004,999,8802,742,8502,273,0701,383,0401,159,580736,566907,8171,117,560973,570890,920486,630638,820
       Short-term Debt 
155,110
130
3,800
8,670
0
0
0
0
363,990
363,990
402,100
2,269,090
2,062,000
2,062,0002,269,090402,100363,990363,99000008,6703,800130155,110
       Short Long Term Debt 
0
0
0
16,030
0
0
0
0
0
0
0
1,789,000
1,533,000
1,533,0001,789,000000000016,030000
       Accounts payable 
169,450
227,090
314,380
328,410
341,510
422,659
523,604
654,510
798,000
1,177,350
1,441,280
1,473,840
1,561,000
1,561,0001,473,8401,441,2801,177,350798,000654,510523,604422,659341,510328,410314,380227,090169,450
       Other Current Liabilities 
302,440
239,460
550,390
610,200
734,430
417,327
163,646
490,860
585,040
61,210
237,000
346,000
316,000
316,000346,000237,00061,210585,040490,860163,646417,327734,430610,200550,390239,460302,440
   > Long-term Liabilities 
122,770
113,100
162,550
208,330
201,760
249,419
283,247
79,530
12,170
929,720
1,110,300
3,096,950
2,162,000
2,162,0003,096,9501,110,300929,72012,17079,530283,247249,419201,760208,330162,550113,100122,770
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
929,720
1,102,750
3,057,000
2,133,230
2,133,2303,057,0001,102,750929,720000000000
       Other Liabilities 
0
0
0
208,330
201,762
242,107
72,950
79,530
12,170
930,000
7,550
40,390
0
040,3907,550930,00012,17079,53072,950242,107201,762208,330000
> Total Stockholder Equity
928,420
1,159,690
1,620,540
2,314,880
3,410,820
5,066,205
6,597,965
7,911,810
9,454,960
10,328,080
12,450,590
15,080,770
16,663,000
16,663,00015,080,77012,450,59010,328,0809,454,9607,911,8106,597,9655,066,2053,410,8202,314,8801,620,5401,159,690928,420
   Common Stock
50,570
50,190
50,200
803,100
812,620
826,770
830,662
833,330
833,420
833,450
833,450
833,450
834,000
834,000833,450833,450833,450833,420833,330830,662826,770812,620803,10050,20050,19050,570
   Retained Earnings 
466,850
721,980
1,117,450
1,423,360
2,097,930
3,046,189
4,309,874
5,764,240
7,188,620
7,892,520
9,810,960
12,089,290
14,530,710
14,530,71012,089,2909,810,9607,892,5207,188,6205,764,2404,309,8743,046,1892,097,9301,423,3601,117,450721,980466,850
   Accumulated Other Comprehensive Income 
-416,800
-533,760
-707,740
-903,920
-1,080,220
-1,256,896
-1,400,604
-444,840
-748,550
-1,351,600
1,078,260
1,319,550
1,507,180
1,507,1801,319,5501,078,260-1,351,600-748,550-444,840-1,400,604-1,256,896-1,080,220-903,920-707,740-533,760-416,800
   Capital Surplus 
0
0
0
0
0
867,600
899,860
926,730
927,620
927,950
927,950
927,950
934,880
934,880927,950927,950927,950927,620926,730899,860867,60000000
   Treasury Stock00-200,030-241,230-277,650-292,430-435,820-437,35000000
   Other Stockholders Equity 
827,800
921,280
1,160,630
992,340
1,580,490
2,450,142
2,858,033
1,759,080
2,181,470
-9,340,510
727,920
838,480
-208,890
-208,890838,480727,920-9,340,5102,181,4701,759,0802,858,0332,450,1421,580,490992,3401,160,630921,280827,800



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue20,169,000
Cost of Revenue-4,472,000
Gross Profit15,697,00015,697,000
 
Operating Income (+$)
Gross Profit15,697,000
Operating Expense-9,480,000
Operating Income3,401,5306,217,000
 
Operating Expense (+$)
Research Development36,000
Selling General Administrative2,820,340
Selling And Marketing Expenses507,800
Operating Expense9,480,0003,364,140
 
Net Interest Income (+$)
Interest Income375,000
Interest Expense-375,000
Other Finance Cost-375,000
Net Interest Income-375,000
 
Pretax Income (+$)
Operating Income3,401,530
Net Interest Income-375,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)3,439,0003,364,790
EBIT - interestExpense = 3,439,000
3,417,000
2,764,000
Interest Expense375,000
Earnings Before Interest and Taxes (EBIT)3,814,0003,814,000
Earnings Before Interest and Taxes (EBITDA)5,316,000
 
After tax Income (+$)
Income Before Tax3,439,000
Tax Provision-1,028,000
Net Income From Continuing Ops2,411,0002,411,000
Net Income2,389,000
Net Income Applicable To Common Shares2,389,000
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses13,952,000
Total Other Income/Expenses Net36,740375,000
 

Technical Analysis of Dr. Lal Path Labs Ltd.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Dr. Lal Path Labs Ltd.. The general trend of Dr. Lal Path Labs Ltd. is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Dr. Lal Path Labs Ltd.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Dr. Lal Path Labs Ltd..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 2,359 < 2,392 < 2,487.

The bearish price targets are: 2,166 > 1,998 > 1,944.

Tweet this
Dr. Lal Path Labs Ltd. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Dr. Lal Path Labs Ltd.. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Dr. Lal Path Labs Ltd. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Dr. Lal Path Labs Ltd.. The current macd is 20.63.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Dr. Lal Path Labs Ltd. price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Dr. Lal Path Labs Ltd.. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Dr. Lal Path Labs Ltd. price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Dr. Lal Path Labs Ltd. Daily Moving Average Convergence/Divergence (MACD) ChartDr. Lal Path Labs Ltd. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Dr. Lal Path Labs Ltd.. The current adx is 18.99.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Dr. Lal Path Labs Ltd. shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Dr. Lal Path Labs Ltd. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Dr. Lal Path Labs Ltd.. The current sar is 2,166.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Dr. Lal Path Labs Ltd. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Dr. Lal Path Labs Ltd.. The current rsi is 62.16. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Dr. Lal Path Labs Ltd. Daily Relative Strength Index (RSI) ChartDr. Lal Path Labs Ltd. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Dr. Lal Path Labs Ltd.. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Dr. Lal Path Labs Ltd. price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Dr. Lal Path Labs Ltd. Daily Stochastic Oscillator ChartDr. Lal Path Labs Ltd. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Dr. Lal Path Labs Ltd.. The current cci is 205.99.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Dr. Lal Path Labs Ltd. Daily Commodity Channel Index (CCI) ChartDr. Lal Path Labs Ltd. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Dr. Lal Path Labs Ltd.. The current cmo is 34.83.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Dr. Lal Path Labs Ltd. Daily Chande Momentum Oscillator (CMO) ChartDr. Lal Path Labs Ltd. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Dr. Lal Path Labs Ltd.. The current willr is -4.95408926.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Dr. Lal Path Labs Ltd. Daily Williams %R ChartDr. Lal Path Labs Ltd. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Dr. Lal Path Labs Ltd..

Dr. Lal Path Labs Ltd. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Dr. Lal Path Labs Ltd.. The current atr is 63.57.

Dr. Lal Path Labs Ltd. Daily Average True Range (ATR) ChartDr. Lal Path Labs Ltd. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Dr. Lal Path Labs Ltd.. The current obv is 16,876,534.

Dr. Lal Path Labs Ltd. Daily On-Balance Volume (OBV) ChartDr. Lal Path Labs Ltd. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Dr. Lal Path Labs Ltd.. The current mfi is 68.50.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Dr. Lal Path Labs Ltd. Daily Money Flow Index (MFI) ChartDr. Lal Path Labs Ltd. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Dr. Lal Path Labs Ltd..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.

6.3. Candlestick Patterns

Dr. Lal Path Labs Ltd. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Dr. Lal Path Labs Ltd. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.160
Ma 20Greater thanMa 502,292.988
Ma 50Greater thanMa 1002,279.638
Ma 100Greater thanMa 2002,403.784
OpenGreater thanClose2,330.650
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Dr. Lal Path Labs Ltd. with someone you think should read this too:
  • Are you bullish or bearish on Dr. Lal Path Labs Ltd.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Dr. Lal Path Labs Ltd.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Dr. Lal Path Labs Ltd.

I send you an email if I find something interesting about Dr. Lal Path Labs Ltd..


Comments

How you think about this?

Leave a comment

Stay informed about Dr. Lal Path Labs Ltd..

Receive notifications about Dr. Lal Path Labs Ltd. in your mailbox!